Knipper Health Acquires eBlu Solutions

Author(s):

Mike Hollan

The therapy initiation partner will integrate the service provider’s technology platform to its national network.

Stock.adobe.com

Knipper Health announced the acquisition of eBlu Solutions, a provider-integrated technology platform.¹ The announcement did not include specifics of the acquisition, although it does cite Frazier Healthcare Partners (a Seattle-based private equity firm) as Knipper Health’s backer. The announcement also specifies eBlu’s platform’s capabilities with real-time medical and pharmacy benefit investigation, electronic prior authorization, and digital patient access enrollment.

Key Takeaways

Knipper Health acquired eBlu Solutions.

Details of the deal were not revealed in the announcement.

The therapy initiation partner will integrate the service provider’s technology platform to its national network.

Why is Knipper acquiring eBlu Solutions?

eBlu states that its platform is able to improve workflow efficiency and reduce delays at the point-of-care. The platform achieves this through automating a majority of the processes. According to the announcement, Knipper plans to integrate eBlu’s services with its existing national fulfillment capabilities in an effort to reduce the amount of time that patients have to wait to start accessing therapy.

In a press release, Knipper Health’s president and CEO Willis Chandler said, “We’re redefining how quickly and efficiently patients begin therapy. By embedding real-time medical and pharmacy automation at the point of care, aligning fulfillment to patient needs, and powering decisions with actionable data, this acquisition accelerates our mission to create a faster, more efficient path from order to therapy.”

In the same press release, eBlu Solutions CEO Mark Murphy added, “

eBlu Solutions has built a trusted network of 15,000 specialty providers across the country. Integrating with Knipper accelerates our ability to expand that network and deepen support for providers and the patients they serve. Together, we dramatically reduce administrative burden and improve the speed and consistency of therapy initiation.”

This news marks the first major announcement of Chandler’s tenure as CEO. The executive was only just announced as Knipper’s president and CEO earlier this month.² Prior to his current role, Chandler served as executive in residence at Frazier, who also announced a significant investment in Knipper alongside Chandler’s move to CEO.

In a press release issued at the time, Nathan Every, general partner at Frazier, said, “Knipper is at the forefront of transforming therapy initiation through a data-enabled, patient-centric platform. We are excited to partner with Willis and the Knipper team to build on the Company’s strong foundation and accelerate its growth. Willis’s experience across commercial pharma services makes him well-suited to lead Knipper through its next chapter.”

In the same press release, Chandler added, “I’m thrilled to join Knipper at a time when we are redefining how quickly and efficiently patients begin therapy. By embedding real-time medical and pharmacy automation at the point of care, aligning fulfillment to patient needs, and powering decisions with actionable data, I look forward to accelerating our mission to create a faster, more efficient path from order to therapy.”

Chandler replaced Michael Laferrera in the role, who served as CEO for the past five-and-a-half years. He also served as president for the past 13 years. He’s cited as having expanded Knipper’s core service offerings. Laferrera oversaw multiple acquisitions during his time as CEO of Knipper.

He will continue as a member of the company’s board of directors.

Frank Segrave, Knipper’s chairman of the board, said in the same press release, “Knipper is very well positioned to lead the next evolution in therapy access through a fully integrated, technology-driven platform. Willis brings the expertise and vision to scale this model for Biopharma, and we look forward to his leadership in our next phase of growth.”

Sources

Knipper Health, Backed by Frazier Healthcare Partners, Acquires eBlu Solutions to Create Industry-Leading Therapy Initiation Platform. Knipper Health. July 17, 2025. https://www.businesswire.com/news/home/20250717879043/en/Knipper-Health-Backed-by-Frazier-Healthcare-Partners-Acquires-eBlu-Solutions-to-Create-Industry-Leading-Therapy-Initiation-Platform
Willis Chandler to Lead Knipper Health as New President and Chief Executive Officer. Knipper Health. July 8, 2025. Accessed July 21, 2025. https://www.businesswire.com/news/home/20250708974509/en/Willis-Chandler-to-Lead-Knipper-Health-as-New-President-and-Chief-Executive-Officer

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!